Published on: 16 June 2021 REGEN-COV™ (casirivimab and imdevimab) phase 3 RECOVERY trial meets primary outcome, improving survival in hospitalized COVID-19 patients lacking an immune response to SARS-CoV-2 more
Published on: 15 June 2021 Roche data at EAN 2021 showcase significant impact of therapies across diverse neuroscience portfolio more
Published on: 11 June 2021 Roche announces data at EHA2021 reinforcing efficacy of Venclexta/Venclyxto combinations in chronic lymphocytic leukaemia and acute myeloid leukaemia more
Latest annual report Highlights Annual Report 2020 How medicines are making an impact in the lives of patients more Annual Report 2020 Finance Report 2020 Roche in Brief 2020
